Search results
Displaying 1 - 10 of 47 results
-
ALERT 17: Alteplase or tenecteplase?
An alert has been issued to highlight the need to clearly differentiate between stroke thrombolysis and myocardial infarction thrombolysis.
-
Specify brand advice guidance – updated July 2023
Refreshed guidelines for the application of specify brand advice (SBA) for medicines within electronic systems.
-
Safety Signal: Changes to the labelling of Bicillin LA®
Following international practice, the name and strength description for Bicillin LA® has been changed. The expression of the name will now be benzathine benzylpenicillin tetrahydrate. The expression of product strength will now be 1,200,000 units/2.3
- Video: Introducing the safe use of opioids collaborative
-
Safe use of opioids collaborative information for DHB hospitals
Information document for DHBs about the breakthrough series collaborative on safe use of opioids in hospitals.
- Benefits and risks of taking anti-seizure medicines for epilepsy, mental health, or pain
-
Opioid implementation package
This package outlines the next steps and what the options are to make a significant difference in opioid-induced adverse drug events.
-
Helen McKernan discusses mother's hospital treatment
Helen McKernan talks about her mother’s death, following a hospital medication error. Helen's mother was given the wrong medication for four days because of a chart mix up and inadequate checking.
-
Medication Safety Factsheet
Reducing medication errors is the focus of a factsheet released today by the Health Quality & Safety Commission.
-
Report COVID-19-related medication errors, challenges and ideas to the New Zealand Pharmacovigilance Centre
The NZPhvC encourages you to report any COVID-19 related medication errors, particular challenges or situations that could lead to errors and any ideas on what measures should be put in place to mitigate errors in the future.